GSP Crop Science Ltd
Company mejorly focusing on fungiside and insecticide and related pesticide
- Market Cap ₹ 2,021 Cr.
- Current Price ₹ 432
- High / Low ₹ 444 / 327
- Stock P/E 23.7
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 20.7 %
- ROE 19.8 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 7.34% over past five years.
- Company has a low return on equity of 13.7% over last 3 years.
- Dividend payout has been low at 3.46% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 903 | 1,077 | 1,406 | 1,203 | 1,152 | 1,287 | |
| 832 | 949 | 1,273 | 1,125 | 1,028 | 1,137 | |
| Operating Profit | 72 | 129 | 132 | 79 | 124 | 150 |
| OPM % | 8% | 12% | 9% | 7% | 11% | 12% |
| 4 | 11 | 13 | 6 | 12 | 14 | |
| Interest | 25 | 18 | 24 | 37 | 34 | 31 |
| Depreciation | 18 | 18 | 20 | 21 | 20 | 23 |
| Profit before tax | 34 | 103 | 101 | 27 | 82 | 110 |
| Tax % | 36% | 34% | 25% | 21% | 26% | 26% |
| 21 | 68 | 76 | 22 | 61 | 82 | |
| EPS in Rs | 72.32 | 229.88 | 256.41 | 77.84 | 235.61 | 21.05 |
| Dividend Payout % | 10% | 4% | 4% | 3% | 4% | 4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | -3% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 2% |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 20% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 27 | 26 | 39 | 39 |
| Reserves | 302 | 366 | 439 | 336 | 344 | 411 | 491 |
| 169 | 139 | 321 | 324 | 235 | 296 | 323 | |
| 242 | 383 | 426 | 444 | 374 | 483 | 639 | |
| Total Liabilities | 742 | 918 | 1,216 | 1,132 | 980 | 1,228 | 1,492 |
| 159 | 161 | 166 | 169 | 177 | 214 | 240 | |
| CWIP | 7 | 9 | 11 | 16 | 51 | 50 | 40 |
| Investments | 2 | 0 | 2 | 3 | 8 | 12 | 19 |
| 573 | 747 | 1,037 | 945 | 745 | 952 | 1,192 | |
| Total Assets | 742 | 918 | 1,216 | 1,132 | 980 | 1,228 | 1,492 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 80 | 114 | -43 | 104 | 207 | 38 | |
| -24 | -19 | -42 | -47 | -19 | -80 | |
| -59 | -50 | 157 | -159 | -178 | 30 | |
| Net Cash Flow | -3 | 45 | 71 | -102 | 10 | -12 |
| Free Cash Flow | 64 | 91 | -93 | 70 | 179 | -34 |
| CFO/OP | 132% | 112% | -22% | 169% | 180% | 45% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 113 | 99 | 96 | 126 | 103 | 110 |
| Inventory Days | 119 | 153 | 148 | 155 | 111 | 173 |
| Days Payable | 113 | 162 | 125 | 156 | 114 | 161 |
| Cash Conversion Cycle | 120 | 90 | 119 | 125 | 99 | 122 |
| Working Capital Days | 54 | 51 | 61 | 56 | 39 | 50 |
| ROCE % | 23% | 19% | 8% | 17% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
29 Apr - ICRA upgraded GSP Crop Science’s ratings on Rs.516.16 crore facilities on April 29, 2026.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
27 Apr - GSP Crop Science says it is not a Large Corporate; outstanding borrowings were Rs 5.82 crore as of March 31, 2026.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 20 Apr
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 Apr - Audio recording of April 17, 2026 post-results conference call for Q3 and nine months ended December 31, 2025.
- Announcement under Regulation 30 (LODR)-Investor Presentation 17 Apr
Concalls
-
Apr 2026Transcript PPT REC
Business Profile[1]
The Company is a research-driven agrochemical company with 40+ years of experience since 1985, focused on the development, manufacturing, and distribution of crop protection products across two verticals — Formulations (finished products) and Technicals (active ingredients).